Informative Tools to Optimize Neoadjuvant Therapy in ER Positive, HER2 Negative Breast Cancers
- Status
- UNKNOWN
- Phase
- NA
Clinical Trials Related to Breast Cancer
Related studies linked through entity extraction aliases.
18F-ASIS PET/CT Imaging of Tissue Factor Expression In Patients With Primary and Metastastic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Minimally Invasive Biopsy Predicting Breast pCR After NAC for Breast Cancer
- Status
- UNKNOWN
- Phase
- NA
NIMBUS: Nivolumab Plus Ipilimumab in Metastatic Hypermutated HER2-negative Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Persistant Organics Pollutants in Breast Cancer.
- Status
- COMPLETED
- Phase
- NA
Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients
- Status
- RECRUITING
- Phase
- NA
ARFI, VisR and DDAI Ultrasound for Improving Discrimination of Malignant and Unresponsive Breast Cancer
- Status
- COMPLETED
- Phase
- N/A
Tissue Expansion in Breast Reconstruction Without Drains
- Status
- COMPLETED
- Phase
- N/A
Acupuncture for Hot Flashes in Hormone Receptor-Positive Breast Cancer, a Randomized Controlled Trial
- Status
- COMPLETED
- Phase
- NA
Distress Reduction by Activity Tracking and Activity Enhancement by Mobile Support Group in Oncology
- Status
- COMPLETED
- Phase
- NA
Pre- or Postoperative Accelerated Radiotherapy
- Status
- COMPLETED
- Phase
- NA
The Effects of Anesthetics on Persistent Pain Following Breast Cancer Surgery
- Status
- COMPLETED
- Phase
- N/A
Understanding and Addressing Patient and Provider Preferences Around Discussions of Cost of Breast Cancer Care
- Status
- COMPLETED
- Phase
- NA
miRNA and Relevant Biomarkers of BC Patients Undergoing Neoadjuvant Treatment
- Status
- UNKNOWN
- Phase
- N/A
Phase 3 Trial of Elacestrant Versus Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Awareness About Breast Cancer Screening
- Status
- COMPLETED
- Phase
- N/A
Study Evaluating GZ17-6.02 in Patients With Advanced Solid Tumors or in Combination With Capecitabine in Metastatic Hormone Receptor Positive Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE1
Pyrotinib, Dalpiciclib(SHR6390) and Endocrine Therapy in Subjects With Dual-receptor Positive(ER+/HER2+) Advanced Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Parallel Comparison of 18 Gene Classifiers and Oncotype DX (Nanostring)
- Status
- COMPLETED
- Phase
- N/A
Team Based Psychosocial Care to Promote, Maintain and Restore Wellness of Breast Cancer Patients
- Status
- COMPLETED
- Phase
- NA